Jeff Thomis
healthcare
Oxonc Development
Korea
Biography
Jeff played a major part in the successful development and registration of eight commercially successful products in the fields of cardiovascular and infectious diseases at Bristol-Myers-Squibb. He was also instrumental in establishing one of the first clinical research centers for a U.S.-based company, conducting mainly IND studies in Europe. Jeff was most recently President of Clinical Development at Quintiles, and managed its unprecedented growth in Europe, including unlocking the potential of Eastern Europe for clinical research. Jeff currently serves as the Chairman of Idis Pharma, a company providing medicines for patients with unmet medical needs, and as a senior advisor to NovaQuest, a health care investment company.
Research Interest
health care
